BioSpace News Archive

BioTelemetry, Inc. (NASDAQ:BEAT) will release its third quarter 2020 earnings on Thursday, October 29 at 4:00 PM Eastern Time.

Retrophin, Inc. (NASDAQ: RTRX) today announced that it has entered into a definitive agreement to acquire Orphan Technologies Limited, a privately held, clinical-stage biopharmaceutical company focused on the development of product candidate OT-58 for the treatment of classical homocystinuria (HCU)

Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing novel vaccines, will report third quarter 2020 financial results on Thursday, November 5, 2020, after the U.S. financial markets close.

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced it will host its third quarter 2020 investor update conference call and webcast at 4:30 p.m. Eastern Time on Thursday, November 5, 2020. Individuals interested in participating in the call should dial (833) 350-1432 (U.S. and Canada) or (647) 689-6932 (international) using conference ID number and event passcode 2794527. To access the webcast, please visit the Invest

-- GFB-887, a first-in-class highly potent and selective inhibitor of the TRPC5-Rac1 pathway, was well-tolerated in single ascending doses -- -- GFB-887 induced dose-dependent reductions in urinary Rac1, demonstrating target engagement -- -- TRPC5-Rac1 pathway overactivation is key cause of disease in substantial portion of patients with focal segmental glomerulosclerosis (FSGS) and diabetic nephropathy (DN) --

Universal Health Services, Inc. (NYSE: UHS) announced today that it will report results for its third quarter ended September 30, 2020 after the market closes on Thursday, October 29, 2020.

- Tivity Health, Inc. (Nasdaq: TVTY) today announced that its financial results for the third quarter ending September 30, 2020 , will be released after market close on Thursday, November 5, 2020 , followed the same day by a conference call and live webcast scheduled for 5:00 p.m. ET . Investors will have the opportunity to l

insitro, a machine learning driven drug discovery and development company, today announced the acquisition of Haystack Sciences, a private company advancing proprietary methods to drive machine-learning enabled drug discovery.

Apollo Medical Holdings, Inc. (“ApolloMed,” and together with its subsidiaries and affiliated entities, the “Company”) (NASDAQ: AMEH), an integrated population health management company, announced today it plans to release consolidated financial results for the third quarter ended September 30, 2020

Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatment of debilitating skin diseases, today announced the pricing of an underwritten public offering of 20,833,322 shares of common stock or common stock equivalents